Molecular, cellular and clinical aspects of parvovirus B19 infection.

Brown KE, Young NS, Liu JM

Crit Rev Oncol Hematol, (1):1-31 1994

MED: 8074799

Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.

Kajigaya S, Fujii H, Field A, Anderson S, Rosenfeld S, Anderson LJ, Shimada T, Young NS

Proc Natl Acad Sci U S A, (11):4646-4650 1991

MED: 1711206

The prevalence of antibody to human parvovirus B19 in England and Wales.

Cohen BJ, Buckley MM

J Med Microbiol, (2):151-153 1988

MED: 3339634

Human parvovirus B19 infections in women of childbearing age and within families.

Koch WC, Adler SP

Pediatr Infect Dis J, (2):83-87 1989

MED: 2539583

Human parvovirus B19 infection among hospital staff members after contact with infected patients.

Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA

N Engl J Med, (8):485-491 1989

MED: 2548096

Parvovirus B19 outbreak on an adult ward.

Seng C, Watkins P, Morse D, Barrett SP, Zambon M, Andrews N, Atkins M, Hall S, Lau YK, Cohen BJ

Epidemiol Infect, (2):345-353 1994

MED: 7925671

Transmission of human parvovirus B19 by coagulation factor concentrates.

Williams MD, Cohen BJ, Beddall AC, Pasi KJ, Mortimer PP, Hill FG

Vox Sang, (3):177-181 1990

MED: 2160147

Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Brown KE, Anderson SM, Young NS

Science, (5130):114-117 1993

MED: 8211117

Further observations on individual differences of human blood

Landsteiner

Proc Soc Exp Biol Med 1927

Title not supplied

Issitt

1985